Mitochondrial Medicine 2021 Virtual
Meet the Faculty
Bill Copeland, PhD
2021 Course Chair
National Institute of Environmental Health Sciences, Durham, NC
Scientific Program Faculty
Friday, May 7, 2021 - 12:00 PM to 1:30 PM EDT
Mitochondria and Metabolism Platform
Click Here to View On-Demand Recording
Dave Pagliarini, PhD
Washington University School of Medicine, St. Louis, MO
Mitochondrial Systems Biochemistry
Heather Christofk, PhD
University of California Los Angeles
Los Angeles, CA
Targeting Cancer Asparagine Dependence
Joshua Rabinowitz, MD, PhD
Princeton University
Princeton, NJ
TCA Cycle Fuels and Fluxes
Poster Abstract Presentations - May 7 - 1:30pm EDT
Abstract Presentations with Live Q&A
- Synthetic Messenger RNA Rescues Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Fibroblasts from Patients and a Murine Model, Xuejun Zhao, University of Pittsburgh, Pittsburgh, PA
- Maladaptive Nutrient Signaling Sustains the m.3243A>G mtDNA Mutation, Chih-Yao Chung, University College of London, UK
- The gnomAD Database of Mitochondrial DNA Variation from 56,434 Individuals, Sarah Calvo, Broad Institute, Cambridge, MA
Scientific Program Faculty
Friday, May 21, 2021 - 12:00 PM to 1:30 PM EDT
Mitochondria and Metabolism Platform
Click Here to View On-Demand Recording
Eric Schon, PhD
Columbia University
New York, NY
Mitochondria in Alzheimer's Disease: It's Not What You Think
Jared Rutter, PhD
University of Utah
Salt Lake City, UT
Metabolism, Cellular Decisions and the Language that Unites Them
Anu Suomalainen, MD, PhD
University of Helsinki
Helsinki, Finland
Shedding Light on Mechanisms of Mitochondrial Brain Diseases
Poster Abstract Presentations - May 21 - 1:30pm EDT
Abstract Presentations with Live Q&A
- A Cardiolipin-Binding Peptide Improves Cellular Bioenergetics in Mitochondrial Trifunctional Protein (TFP)-Deficient Mice and Patient Fibroblasts, Meicheng Wang, University of Pittsburgh, PA
- Mitochondrial Protein Import Clogging as a Mechanism of Disease, Liam Coyne, SUNY Upstate Medical University, Syracuse, NY
- SLC25A46 Organizes a Platform for Mitochondrial Membrane Dynamics and Lipid Remodeling, Jana Schuettpelz, McGill University, Montreal, Quebec
Scientific Program Faculty
Friday, June 4, 2021 - 12:00 PM to 1:30 PM EDT
Gene Editing/Gene Therapy Platform
Click Here to View On-Demand Recording
Carlos Moraes, PhD
University of Miami
Miami, FL
Progress on Gene Therapy for mtDNA Diseases
Steven Gray, PhD
University of Texas Southwestern Medical Center, Dallas, TX
Gene Therapy for SURF1-related Leigh Syndrome
Mickael Decressac, PhD
Grenoble Institute of Neuroscience (GIN), France
Towards Gene Therapy for Leigh Syndrome
Poster Abstract Presentations - June 4 - 1:30pm EDT
Abstract Presentations with Live Q&A
- Modulation of the Nuclear Epigenome as a New Strategy for Mitochondrial DNA Heteroplasmy Shift, Lia Mayorga, IHEM, Argentina
- Assessment of Lenadogene Nolparvovec (rAAV2/2-ND4) Gene Therapy Efficacy in Leber Hereditary Optic Neuropathy Using an External Control Group, Mark Moster, Thomas Jefferson University, Philadelphia, PA
- Gene Replacement Therapy for SURF1-Related Leigh Syndrome Using AAV9, Qinglan Ling, UT Southwestern, Dallas, TX
Scientific Program Faculty
Friday, June 18, 2021 - 12:00 PM to 1:30 PM EDT
Mitochondria in Stress Platform
Click Here to View On-Demand Recording
Vamsi Mootha, MD
Harvard Medical School
Boston, MA
Mitochondria, Oxygen, and Human Disease
Phillip West, PhD
Texas A&M University College of Medicine, Bryan, TX
Mitochondrial Control of Innate Immunity and Inflammation
Poster Abstract Presentations - June 18 - 1:30pm
Abstract Presentations with Live Q&A
- Characterization of Two Variants in the Mitochondrial Topoisomerase Gene TOP1MT Reveal a Potential Involvement in Human Pathology, Iman Al Khatib, University of Calgary, Alberta, CA
- Identification of Novel Compounds to Treat Rare Mitochondrial Diseases, Arwen Gao, EPFL (École polytechnique fédérale de Lausanne), Switzerland
- Vaccine Hesitancy toward the COVID19 Vaccine and Attitudes toward Ring Vaccination by Caregivers of Children with Mitochondrial Disease, Eliza Gordon-Lipkin, National Institute of Health, Bethesda, MD